Stratifin (SFN, 14-3-3 sigma), as an oncogene related to cell proliferation, facilitates the development and progression of a variety of cancers (31, 32) including gliomas (33) and has the potential to be a new therapeutic target. This evidence concerns the gene SFN and central nervous system cancer.